Mohammad Javad Mehran

Dr. Mohammad Javad Mehran


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2025 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
MBMansoor Bolideei
Mansoor Bolideei
RBRambod Barzigar
Rambod Barzigar
RGRazieh Bahrami Gahrouei
Razieh Bahrami Gahrouei
EMElham Mohebbi
Elham Mohebbi
KHKhawaja Husnain Haider
Khawaja Husnain Haider
MMMohammad Javad Mehran
Mohammad Javad Mehran

2 February 2026 in Drug Development Research
Verified
Journal Article
Closed access
MMMohammad Javad Mehran
Mohammad Javad Mehran
SMSara Mohammadzadeh
Sara Mohammadzadeh
MBMansoor Bolideei
Mansoor Bolideei
RBRambod Barzigar
Rambod Barzigar
KHKhawaja Husnain Haider
Khawaja Husnain Haider
YBYadollah Bahrami
Yadollah Bahrami

29 August 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
YBYadollah Bahrami
Yadollah Bahrami
MBMansoor Bolideei
Mansoor Bolideei
SMSara Mohammadzadeh
Sara Mohammadzadeh
RGRazieh Bahrami Gahrouei
Razieh Bahrami Gahrouei
EMElham Mohebbi
Elham Mohebbi
MMMohammad Javad Mehran
Mohammad Javad Mehran

6 January 2025 in Indian Journal of Pharmaceutical Education and Research
Verified
Journal Article
Open access
PDF file
MMMohammad Javad Mehran
Mohammad Javad Mehran
RBRambod Barzigar
Rambod Barzigar
BKBasaralu Yadurappa Sathish Kumar
Basaralu Yadurappa Sathish Kumar
NHNanjundappa Haraprasad
Nanjundappa Haraprasad
BFBashasab Fakrudin
Bashasab Fakrudin
MBMansoor Bolideei
Mansoor Bolideei
Background Helicobacter pylori is implicated in several severe gastrointestinal disorders, including gastric cancer, affecting a significant global population. This study aims to exploit plant biotechnology for vaccine development by engineering brinjal (Solanum melongena L.) to express H. pylori’s cytotoxin-associated gene A (cagA) antigen. Utilizing transgenic plants as an innovative strategy not only mitigates the high costs associated with traditional vaccine production but also leverages their capacity to induce a mucosal immune response. Materials and Methods We used the brinjal variety ‘Arka Keshav’ for transformation. The cagA gene from H. pylori strain 26695 was cloned into the pBI121 vector and transferred into brinjal using Agrobacterium tumefaciens-mediated transformation. Transgenic expression was verified through PCR, quantitative real-time PCR (qPCR), Western blotting and ELISA. Immunohistochemistry was used to assess the localization of the cagA protein within the plant tissues. Results Cloning and amplification confirmed the insertion of the cagA gene approximately ~1700 bp in size. Transgenic brinjal lines were successfully generated, with distinct expression levels of cagA observed. ELISA and Western blot analyses indicated significant cagA protein expression, particularly in lines B11 and B17, which showed the highest antigen concentrations. The consistency of mRNA and protein expression validated the effectiveness of the transgenic approach. Conclusion The study demonstrates the feasibility of using genetically modified brinjal as a platform for producing edible vaccines against H. pylori. This approach not only presents a cost-effective alternative to traditional vaccines but also offers potential for enhancing accessibility in regions burdened by gastric diseases associated with H. pylori. Future research should focus on optimizing expression systems and evaluating the clinical efficacy of these plant-based vaccines.

1 December 2021 in Indian Journal of Pharmaceutical Education and Research
Verified
Journal Article
Open access
MMMohammad Javad Mehran
Mohammad Javad Mehran
BKBasaralu Yadurappa Sathish Kumar
Basaralu Yadurappa Sathish Kumar
NHNanjundappa Haraprasad
Nanjundappa Haraprasad
RBRambod Barzigar
Rambod Barzigar
BFBashasab Fakrudin
Bashasab Fakrudin
SPSayan Paul
Sayan Paul

31 July 2026 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
CHCheng Hao
Cheng Hao
MBMansoor Bolideei
Mansoor Bolideei
JAJamal Alshorman
Jamal Alshorman
KTKingsley Miyanda Tembo
Kingsley Miyanda Tembo
MYMahdi Morshedi Yekta
Mahdi Morshedi Yekta
ZZZhe Zhang
Zhe Zhang
Stem-cell-based interventions encompass biologically distinct therapeutic strategies with markedly different levels of clinical maturity. Hematopoietic ste